Saltar al contenido
Merck
  • Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.

Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.

Pharmaceutical research (2014-01-29)
Koen van der Maaden, Sebastiaan J Trietsch, Heleen Kraan, Eleni Maria Varypataki, Stefan Romeijn, Raphäel Zwier, Heiko J van der Linden, Gideon Kersten, Thomas Hankemeier, Wim Jiskoot, Joke Bouwstra
RESUMEN

The aim of the study was to develop a cheap and fast method to produce hollow microneedles and an applicator for injecting vaccines into the skin at a pre-defined depth and test the applicability of the system for dermal polio vaccination. Hollow microneedles were produced by hydrofluoric acid etching of fused silica capillaries. An electromagnetic applicator was developed to control the insertion speed (1-3 m/s), depth (0-1,000 μm), and angle (10°-90°). Hollow microneedles with an inner diameter of 20 μm were evaluated in ex vivo human skin and subsequently used to immunize rats with inactivated poliovirus vaccine (IPV) by an intradermal microinjection of 9 μL at a depth of 300 μm and an insertion speed of 1 m/s. Rat sera were tested for IPV-specific IgG and virus-neutralizing antibodies. Microneedles produced from fused silica capillaries were successfully inserted into the skin to a chosen depth, without clogging or breakage of the needles. Intradermal microinjection of IPV induced immune responses comparable to those elicited by conventional intramuscular immunization. We successfully developed a hollow microneedle technology for dermal vaccination that enables fundamental research on factors, such as insertion depth and volume, and insertion angle, on the immune response.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Peróxido de hidrógeno solution, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Peróxido de hidrógeno solution, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Peróxido de hidrógeno solution, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.
Sigma-Aldrich
3,3′,5,5′-Tetrametilbencidina, ≥99%
Sigma-Aldrich
Peróxido de hidrógeno solution, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 35 wt. % in H2O
Sigma-Aldrich
Peróxido de hidrógeno solution, purum p.a., ≥35% (RT)
Sigma-Aldrich
3,3′,5,5′-Tetrametilbencidina, ≥98% (TLC)
Millipore
Peróxido de hidrógeno solution, 3%, suitable for microbiology
Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Supelco
Peróxido de hidrógeno solution, ≥30%, for trace analysis
Sigma-Aldrich
Peróxido de hidrógeno solution, 34.5-36.5%
Sigma-Aldrich
3,3′,5,5′-Tetrametilbencidina, ≥98.0% (NT)
Sigma-Aldrich
Peróxido de hidrógeno solution, SAJ first grade, ≥30.0%
Sigma-Aldrich
3,3′,5,5′-Tetrametilbencidina, tablet, 1 mg substrate per tablet
Supelco
Peróxido de hidrógeno solution, 30 % (w/w), for ultratrace analysis
Sigma-Aldrich
Peróxido de hidrógeno solution, tested according to Ph. Eur.
Sigma-Aldrich
Peróxido de hidrógeno solution, contains potassium stannate as inhibitor, 30-32 wt. % in water, semiconductor grade, 99.999% trace metals basis
Supelco
3,3′,5,5′-Tetrametilbencidina, standard for GC